Cytek expects its total revenue for the full year 2025 to be approximately $201 million. Expected revenue for the fourth quarter of 2025 of approximately $62 million represents growth of 8% compared ...
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the fourth ...
News Medical on MSN
Web-based cytometry atlas reveals immune signatures across pancreatic cancer treatments
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...
Learn how to tell if your business could be facing a cash crunch—and what to do about it Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results